Two new cases of near-tetraploidy in adult acute myeloid leukemia

Cancer Genetics and Cytogenetics
B EspinetJ Sans-Sabrafen

Abstract

Tetraploid or near-tetraploid karyotype has been described rarely in hematologic neoplasms. Herein we report two new cases of adult acute myeloblastic leukemia, M0 and M1 FAB subtypes that showed near-tetraploid clones that were studied with conventional cytogenetics and in situ hybridization (ISH). We compare our new cases with those previously reported.

References

Jul 15, 1988·Cancer Genetics and Cytogenetics·H HarthH Zankl
Nov 1, 1987·Cancer Genetics and Cytogenetics·S HeimF Mitelman
Jun 1, 1986·Cancer Genetics and Cytogenetics·S Heim, F Mitelman
Jan 1, 1985·Cancer Genetics and Cytogenetics·R AbeA A Sandberg
Jun 1, 1985·Cancer Genetics and Cytogenetics·M J Kocova, A A Sandberg
Nov 1, 1993·Cancer Genetics and Cytogenetics·C MarosiO A Haas
Feb 1, 1996·Cancer Genetics and Cytogenetics·M R ClarkeS Shekhter-Levin
Apr 1, 1997·Cancer Genetics and Cytogenetics·F SoléJ Esquivias

❮ Previous
Next ❯

Citations

Jun 20, 2015·American Journal of Hematology·Vladimir LazarevicBertil Johansson
Jan 8, 2015·Journal of Clinical Pathology·Changlee S PangTimothy S Pardee
Jul 3, 2002·Leukemia·O Hrusák, A Porwit-MacDonald
Oct 26, 2005·Bone Marrow Transplantation·M GorschlüterI G H Schmidt-Wolf
Mar 27, 2004·Archives of Pathology & Laboratory Medicine·Marwa ImkieMark T Cunningham

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.